Wednesday, 8 September 2010
|
||||
| Boston | Delft | Tokyo | ||
Pyxis Discovery designs screening libraries containing compounds that are novel, lead-like, and pure and that have inherent possibilities for lead optimization.
The most recent scientific insights with respect to ‘drugability’ of compounds are incorporated in the design of Smart Libraries. Pyxis Discovery designs novel chemical compounds by making smart use of available data on known biologically active compounds.
Our latest Smart Libraries are offered on an exclusive basis only, meaning that each library of approximately 500 compounds will be sold to just one client. We currently have more than 4,000 exclusive compounds for sale and 1,000 novel compounds will be added every month.
We also have more than 8,000 leadlike compounds available for sale on a non-exclusive basis.
Both the exclusive, as well as the non-exclusive Smart Libraries are offered without any intellectual property rights being retained by Pyxis Discovery.
Smart Libraries consist of compounds that have been analyzed by LC/MS and H-NMR. All compounds have a minimum purity of 90%.